Colorectal Cancer in the Course of Familial Adenomatous Polyposis Syndrome ("de novo" Pathogenic Mutation of APC Gene): Case Report, Review of the Literature and Genetic Commentary | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
scientific articles

Colorectal Cancer in the Course of Familial Adenomatous Polyposis Syndrome (“de novo” Pathogenic Mutation of APC Gene): Case Report, Review of the Literature and Genetic Commentary

key information

source: Archives of medical science

year: 2010

authors: Stec R, Pławski A, Synowiec A, Mączewski M, Szczylik C

summary/abstract:

Colorectal cancer (CRC) is one of the most common malignant tumours in Poland. Annually approximately 11 000 new cases of CRC are diagnosed, while the number of deaths caused by CRC approaches 8 000. Five-year survival does not exceed 20%. Familial adenomatous polyposis (FAP) is responsible for about 1% of new cases of CRC. The risk of CRC in FAP syndrome is 100%, and the average age of CRC development is 39 years. Early colectomy is the most effective method of CRC prevention. We report an atypical case of CRC in a patient with FAP caused by 2797-2800delAACA mutation of the APC gene.

organization: Warsaw Military Institute of Medicine

DOI: 10.5114/aoms.2010.13911

read more

expertly curated content related to this topic

en English
en Englishpt Portuguesees Spanish

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close